ATLN
vs
S&P 500
ATLN
S&P 500
Over the past 12 months, ATLN has outperformed S&P 500, delivering a return of +26% compared to the S&P 500's +12% growth.
Stocks Performance
ATLN vs S&P 500
Performance Gap
ATLN vs S&P 500
Performance By Year
ATLN vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SeqLL Inc
Glance View
SeqLL, Inc. engages in the design, development, and manufacture of genetic analysis technologies. The company is headquartered in Woburn, Massachusetts and currently employs 7 full-time employees. The company went IPO on 2021-08-27. The company offers ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sequencing solutions. The company uses its true single molecule sequencing (tSMS) technology. SeqLL offers RNA and specialty DNA sequencing services utilizing tSMS. SeqLL offers a range of RNA sequencing services, including its direct RNA sequencing without conversion to complementary DNA (cDNA). The firm operates in a single business segment that includes the design, development and manufacturing of genetic analysis technologies. Its testing services are fully customizable to customers research needs and challenges. Its SeqLL technology is used for various application, such as life sciences research and development, liquid biopsy, clinical diagnostics and microbiome analysis. The tSMS platform offers a sample preparation process.
